Medi-Cal: organ transplants: antirejection medication.

Existing law establishes the Medi-Cal program, administered by the State Department of Health Care Services, under which basic health care services are provided to qualified low-income persons. Under existing law, organ transplants and donor surgeries are covered as reimbursable services under the Medi-Cal program. This bill would provide that a Medi-Cal beneficiary shall remain eligible to receive Medi-Cal coverage for antirejection medication for up to 2 years following an organ transplant, unless during that period the beneficiary becomes eligible for Medicare or private health insurance that would cover the medication.